This inventor holds 1 USPTO granted patent. Top assignee: Genzyme Corporation. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Marko J Pregel: Innovator in Pharmaceutical Science
Introduction
Marko J Pregel is a notable inventor based in Arlington, MA (US). He has made significant contributions to the field of pharmaceutical science, particularly in the development of treatments for diseases related to protein trafficking.
Latest Patents
Marko J Pregel holds 1 patent for his work on "Tetrahydroisoquinoline derivatives for treating protein trafficking diseases." This patent discloses tetrahydroisoquinoline derivatives, pharmaceutical compositions comprising them, and methods for treating diseases. The compounds are particularly useful in treating and preventing diseases mediated by chloride channel activity and/or protein trafficking. These include conditions associated with impaired mucociliary clearance, such as cystic fibrosis, bronchitis, and emphysema.
Career Highlights
Marko is currently employed at Genzyme Corporation, where he continues to innovate in the pharmaceutical sector. His work focuses on developing new therapeutic strategies to address complex medical conditions.
Collaborations
Throughout his career, Marko has collaborated with esteemed colleagues, including Bradford Hirth and John L Kane, Jr. These partnerships have contributed to the advancement of research and development in his field.
Conclusion
Marko J Pregel's contributions to pharmaceutical science highlight his commitment to improving treatments for serious health conditions. His innovative work continues to impact the medical community positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile